Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Genentech, Inc. - Product Pipeline Review - 2014 - New Market Report


Print article Print article
2014-03-17 12:48:44 - New Pharmaceuticals market report from Global Markets Direct: "Genentech, Inc. - Product Pipeline Review - 2014"

Global Market Direct's pharmaceuticals report, "Genentech, Inc. - Product Pipeline Review - 2014" provides data on the Genentech, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Genentech, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Genentech, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Report Scope

* Genentech, Inc. - Brief Genentech, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Genentech, Inc. human therapeutic division.
*

Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Genentech, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Genentech, Inc.'s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Full Report Details at
- www.fastmr.com/prod/778134_genentech_inc_product_pipeline_review ..

Reasons to Get this Report

* Evaluate Genentech, Inc.'s strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Genentech, Inc. in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Genentech, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Genentech, Inc..
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Genentech, Inc. and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
List of Tables
List of Figures
Genentech, Inc. Snapshot
Genentech, Inc. Overview
Key Information
Key Facts
Genentech, Inc. - Research and Development Overview
Key Therapeutic Areas
Genentech, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Pipeline Products - Out-Licensed Products
Genentech, Inc. - Pipeline Products Glance
Genentech, Inc. - Late Stage Pipeline Products
Genentech, Inc. - Clinical Stage Pipeline Products
Genentech, Inc. - Early Stage Pipeline Products
Genentech, Inc. - Drug Profiles
RG-7446
apitolisib
crenezumab
etrolizumab
ipatasertib
lampalizumab
MHAA-4549A
pictilisib
quilizumab
RG-7446 + bevacizumab
RG-7593
RG-7596
RG-7597
RG-7599
RG-7652
RG-7667
rontalizumab
GDC-0032
TNX-234
cobimetinib
DMUC-5754-A
GDC-0084
GDC-0425
GDC-0834
GDC-0853
GDC-0994
parsatuzumab
RG-7446 + vemurafenib
RG-7450
RG-7598
RG-7600
RG-7624
RG-7636
RG-7741
BV-6
Compound-29
CS-3
G-007-LK
G-244-LM
GNE-293
GNE-317
GNE-7915
Monoclonal Antibody 30D8
Monoclonal Antibody To Inhibit Tau For Alzheimers Disease
MV-1
Nampt Inhibitors
Small Molecules To Inhibit JAK2 For Cancer
Small Molecules To Inhibit JAK2 For Myeloproliferative Neoplasms
Small Molecules To Inhibit Mammalian Rapamycin Kinase For Cancer
Small Molecules To Inhibit NAMPT For Cancer
Triazolopyridine-9
AMRBAC-1
AMRBAC-2
AMRBAC-3
Benzoxazepin PI3K Inhibitors
Compound-37
Small Molecules For Bacterial Infections
Small Molecules To inhibit Human Lactate Dehydrogenase
Small Molecules To Inhibit Jak1/2 For Hematopoietic and Immunologic diseases
Small Molecules To inhibit PI3-Kinase Delta For Inflammatory and Leukocyte disorders
Small molecules To Inhibit Pim Kinase For Cancer
Genentech, Inc. - Pipeline Analysis
Genentech, Inc. - Pipeline Products by Therapeutic Class
Genentech, Inc. - Pipeline Products by Target
Genentech, Inc. - Pipeline Products by Route of Administration
Genentech, Inc. - Pipeline Products by Molecule Type
Genentech, Inc. - Pipeline Products by Mechanism of Action
Genentech, Inc. - Recent Pipeline Updates
Genentech, Inc. - Dormant Projects
Genentech, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
Genentech, Inc. - Company Statement
Genentech, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Genentech, Inc. - Key Manufacturing Facilities
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Genentech, Inc., Key Information
Genentech, Inc., Key Facts
Genentech, Inc. - Pipeline by Indication, 2014
Genentech, Inc. - Pipeline by Stage of Development, 2014
Genentech, Inc. - Monotherapy Products in Pipeline, 2014
Genentech, Inc. - Combination Treatment Modalities in Pipeline, 2014
Genentech, Inc. - Partnered Products in Pipeline, 2014

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=778134&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com